INTERNATIONAL JOURNAL OF DRUG POLICY

metrics 2024

Driving Informed Policy through Rigorous Research

Introduction

International Journal of Drug Policy, published by Elsevier, stands as a crucial scholarly platform dedicated to advancing the field of drug policy research. With an impactful focus on health policy and medicine, this journal holds a prestigious Q1 ranking in both Health Policy and Medicine (miscellaneous) categories as of 2023, reflecting its high-quality contributions to the discourse surrounding drug use, regulation, and public health. Spanning publication from 1998 to 2024, the journal's rich archive of research serves as an essential resource for researchers, professionals, and students alike. While the journal is not open access, it provides invaluable insights and significant findings that drive policy-making decisions and foster evidence-based practices in drug management and health interventions. With a Scopus rank of #28 out of 310 in Health Policy and #55 out of 398 in Medicine (miscellaneous), the International Journal of Drug Policy is indispensable for those committed to exploring and understanding the complexities of drug-related issues on a global scale.

Metrics 2024

SCIMAGO Journal Rank1.36
Journal Impact Factor4.40
Journal Impact Factor (5 years)4.70
H-Index98
Journal IF Without Self4.40
Eigen Factor0.02
Normal Eigen Factor3.60
Influence1.53
Immediacy Index0.80
Cited Half Life4.70
Citing Half Life5.50
JCI1.40
Total Documents3587
WOS Total Citations9854
SCIMAGO Total Citations30187
SCIMAGO SELF Citations4659
Scopus Journal Rank1.36
Cites / Document (2 Years)4.06
Cites / Document (3 Years)4.31
Cites / Document (4 Years)4.59

Metrics History

Rank 2024

Scopus

Health Policy in Medicine
Rank #28/310
Percentile 90.97
Quartile Q1
Medicine (miscellaneous) in Medicine
Rank #55/398
Percentile 86.18
Quartile Q1

IF (Web Of Science)

SUBSTANCE ABUSE
Rank 4/55
Percentile 93.60
Quartile Q1

JCI (Web Of Science)

SUBSTANCE ABUSE
Rank 4/55
Percentile 92.73
Quartile Q1

Quartile History

Similar Journals

DRUG AND ALCOHOL REVIEW

Transforming research into impactful practices.
Publisher: WILEYISSN: 0959-5236Frequency: 6 issues/year

DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.

Current Drug Safety

Advancing the Frontiers of Drug Safety Research
Publisher: BENTHAM SCIENCE PUBLISSN: 1574-8863Frequency: 3 issues/year

Current Drug Safety is a distinguished peer-reviewed journal published by Bentham Science Publishers, focusing on the critical intersection of pharmacology and toxicology. With an ISSN of 1574-8863 and an E-ISSN of 2212-3911, this journal serves as a platform for the latest research and advances in drug safety, highlighting the importance of pharmacological assessments and toxicity evaluations in therapeutic development and public health. Reaching a broad international audience from its base in the United Arab Emirates, Current Drug Safety offers an invaluable resource for researchers, professionals, and students interested in the dynamic fields of drug research and safety management. Despite a current Q3 categorization in multiple pharmacology and toxicology quartiles for 2023, the journal continues to strive for excellence in the scholarly community, reflecting its commitment to disseminating high-quality research. While not operating under an open access model, articles can be accessed through institutional subscriptions and other platforms, ensuring valuable insights into drug safety are available to those who need it most.

SUBSTANCE USE & MISUSE

Exploring the complexities of substance use for a healthier future.
Publisher: TAYLOR & FRANCIS INCISSN: 1082-6084Frequency: 14 issues/year

SUBSTANCE USE & MISUSE, published by Taylor & Francis Inc, is an esteemed academic journal dedicated to the multifaceted study of substance use and its implications on health and society. With a notable impact factor and categorized in the Q2 quartile across multiple fields—including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, as well as Public Health—this journal serves as an essential platform for researchers, professionals, and students alike. Spanning from 1966 to 2024, it provides a rich archive of peer-reviewed articles that explore current trends, innovative research, and evidence-based practices in the management and understanding of substance use. The journal offers various access options, catering to the diverse needs of its audience and affirming its commitment to fostering scholarly discourse in the United Kingdom and beyond. By engaging with this journal, readers can enhance their understanding of the complexities surrounding substance use, making it a crucial resource for advancing knowledge and informing policy in this critical area of public health.

Journal of Substance Use & Addiction Treatment

Innovating solutions for addiction recovery.
Publisher: ELSEVIER SCIENCE INCISSN: 2949-8767Frequency: 12 issues/year

Journal of Substance Use & Addiction Treatment is a premier scholarly publication dedicated to advancing the understanding and treatment of substance use disorders and addictive behaviors. Published by Elsevier Science Inc, this journal serves as a vital platform for researchers, clinicians, and students in the fields of psychology, psychiatry, public health, and addiction studies. With its commitment to Open Access, the journal facilitates wide dissemination of cutting-edge research, enabling practitioners and policymakers to access critical findings that inform treatment approaches and public health strategies. As an essential resource in addiction treatment and research, the Journal of Substance Use & Addiction Treatment aims to foster interdisciplinary collaboration and innovation, ultimately improving outcomes for individuals affected by addiction.

Cultura y Droga

Innovating Perspectives in the Study of Culture and Drugs
Publisher: UNIV CALDASISSN: 0122-8455Frequency: 1 issue/year

Cultura y Droga is a prominent journal dedicated to the interdisciplinary study of culture and drug use, published by UNIV CALDAS in Colombia. With its Open Access policy implemented since 2015, this journal strives to make significant research accessible to a global audience, fostering dialogue and innovation in the field. Although specific metrics such as HIndex and Scopus ranks are not provided, the journal is committed to publishing high-quality, peer-reviewed articles that explore the sociocultural dimensions of drug consumption and its implications on public health, policy, and society at large. Researchers, professionals, and students will find this journal an essential resource for advancing their understanding and contributing to critical discussions surrounding drug culture.

Sucht-Zeitschrift fur Wissenschaft und Praxis

Advancing knowledge in addiction science and mental health.
Publisher: HOGREFE AG-HOGREFE AG SUISSEISSN: 0939-5911Frequency: 6 issues/year

Sucht-Zeitschrift für Wissenschaft und Praxis, published by HOGREFE AG in Switzerland, is a pivotal journal addressing the interrelated fields of addiction science and mental health. With an ISSN of 0939-5911 and an E-ISSN of 1664-2856, this journal has been dedicated to fostering interdisciplinary research and practical applications since its inception in 1991, continuing through to 2024. As a respected source in the field, it holds a 2023 Q3 quartile ranking in Medicine (miscellaneous), a Q4 ranking in Psychiatry and Mental Health, and a Q3 ranking in Public Health, highlighting its broad relevance and growing impact on contemporary health discussions. While currently not offering open access options, the journal provides a rich platform for researchers, practitioners, and students to share and gain insights into innovative practices and scientific findings that advance the understanding of addiction and its societal implications. With its contributions indexed in Scopus and a variety of rankings reflective of its quality, Sucht-Zeitschrift für Wissenschaft und Praxis serves as an essential resource for those committed to advancing knowledge and practice in addiction-related fields.

NICOTINE & TOBACCO RESEARCH

Advancing knowledge on nicotine and tobacco for a healthier tomorrow.
Publisher: OXFORD UNIV PRESSISSN: 1462-2203Frequency: 12 issues/year

NICOTINE & TOBACCO RESEARCH, published by Oxford University Press, is a leading journal dedicated to advancing the understanding of nicotine and tobacco-related issues through rigorous research and analysis. Established in 1999, this esteemed journal has become a critical resource for scholars and practitioners in the fields of public health, environmental, and occupational health, maintaining a prestigious Q1 classification in its category as of 2023. With an impressive ranking of 67 out of 665 in the Scopus database, placing it in the 90th percentile, it is recognized for its high-quality contributions that resonate with current global health challenges. Although open access options are not available, the journal’s articles are accessible to a broad audience, ensuring that cutting-edge research reaches those who need it most. As it looks toward 2024 and beyond, NICOTINE & TOBACCO RESEARCH remains committed to promoting innovative research that informs policies and practices aimed at reducing tobacco use and its associated harms, thus playing a pivotal role in enhancing public health worldwide.

International Journal of Alcohol and Drug Research

Shaping the future of substance abuse research.
Publisher: OHIO STATE UNIV, COLL SOCIAL WORKISSN: 1925-7066Frequency: 4 issues/year

Welcome to the International Journal of Alcohol and Drug Research, an esteemed publication dedicated to advancing the understanding and research surrounding alcohol and drug-related issues. Published by Ohio State University, College of Social Work, this journal serves as a vital resource for professionals and scholars engaged in social sciences, public health, and epidemiological studies. Established as an Open Access journal since 2012, it ensures that valuable research findings are readily accessible to all, promoting awareness and disseminating knowledge critical in the fight against substance abuse. With a commendable impact in the field, the journal occupies a notable position in Scopus rankings, showcasing its contribution to social health, public health, and epidemiology. Covering an extensive scope with a commitment to rigorous research, the journal aims to foster collaboration between researchers, policymakers, and practitioners, ultimately driving innovative solutions and best practices in the realm of alcohol and drug research.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Innovating research for safer medication practices.
Publisher: WILEYISSN: 1053-8569Frequency: 12 issues/year

Pharmacopidemiology and Drug Safety is a prestigious academic journal published by Wiley, dedicated to exploring the field of pharmacology and epidemiological studies since its inception in 1992. With its ISSN 1053-8569 and E-ISSN 1099-1557, the journal has achieved notable recognition, ranking Q2 in Epidemiology and Q1 in Medical Pharmacology in the 2023 category quartiles. Its Scopus rankings further enhance its reputation, placing it at 105th in the field of pharmacology and at 63rd in epidemiology, reflecting its commitment to publishing high-quality research that informs clinical practices and public health policies. Although it operates under a subscription model rather than open access, Pharmacopidemiology and Drug Safety plays a critical role in disseminating vital knowledge regarding drug safety and effectiveness, making it an essential resource for researchers, professionals, and students looking to stay at the forefront of advancements in the medical field.

Justice Evaluation Journal

Evaluating justice, shaping reform.
Publisher: TAYLOR & FRANCIS LTDISSN: 2475-1979Frequency: 2 issues/year

Welcome to the Justice Evaluation Journal, a leading publication in the field of law, published by Taylor & Francis Ltd, renowned for its commitment to advancing scholarly discourse. With an ISSN of 2475-1979 and an E-ISSN of 2475-1987, this journal has established itself as a pivotal resource for researchers, practitioners, and students from its inception in 2018 through to its ongoing contributions in 2024. Achieving a prestigious Q1 ranking in the law category, and earning a remarkable 90th percentile rank in Scopus, the journal is dedicated to evaluating and disseminating critical insights on justice systems and reform. Although not an open-access journal, it continues to foster deep scholarly engagement through a rigorous peer-review process. The Justice Evaluation Journal serves as an essential platform for those committed to improving the effectiveness and fairness of legal institutions worldwide, making it indispensable in your academic and professional journey.